Adial Pharmaceuticals Inc Sustainability Reports
A clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, including alcohol use disorder (AUD).
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
2 reports from 2023 to 2024
Company Profile
A clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, including alcohol use disorder (AUD).
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
